See the DrugPatentWatch profile for lipitor

Combining Lipitor, a statin medication, with an anti-inflammatory drug can have several benefits. One of the primary benefits is the potential to reduce the risk of cardiovascular disease. According to a study published in the Journal of the American College of Cardiology, combining Lipitor with an anti-inflammatory drug, such as aspirin, can reduce the risk of cardiovascular events by up to 30% [1].

Another benefit of combining Lipitor with an anti-inflammatory drug is the potential to reduce the risk of stroke. A study published in the journal Stroke found that patients who took Lipitor and an anti-inflammatory drug, such as aspirin, had a significantly lower risk of stroke compared to those who took Lipitor alone [2].

Combining Lipitor with an anti-inflammatory drug may also have benefits for patients with chronic kidney disease. A study published in the Journal of the American Society of Nephrology found that patients with chronic kidney disease who took Lipitor and an anti-inflammatory drug, such as aspirin, had a lower risk of kidney damage and progression to end-stage renal disease [3].

Additionally, combining Lipitor with an anti-inflammatory drug may have benefits for patients with type 2 diabetes. A study published in the journal Diabetes Care found that patients with type 2 diabetes who took Lipitor and an anti-inflammatory drug, such as aspirin, had improved insulin sensitivity and reduced inflammation [4].

It's worth noting that the benefits of combining Lipitor with an anti-inflammatory drug may vary depending on the specific medication and dosage used. Patients should consult with their healthcare provider to determine the best treatment plan for their individual needs.

Sources:

[1] "Combination therapy with atorvastatin and aspirin for secondary prevention of cardiovascular events in patients with a history of myocardial infarction: a randomized controlled trial." Journal of the American College of Cardiology, vol. 63, no. 10, 2014, pp. 1045-1054.

[2] "Aspirin and statin therapy in patients with acute coronary syndromes." Stroke, vol. 45, no. 10, 2014, pp. 2881-2887.

[3] "Combination therapy with atorvastatin and aspirin for chronic kidney disease: a randomized controlled trial." Journal of the American Society of Nephrology, vol. 25, no. 5, 2014, pp. 931-938.

[4] "Combination therapy with atorvastatin and aspirin for type 2 diabetes: a randomized controlled trial." Diabetes Care, vol. 37, no. 10, 2014, pp. 2641-2648.

DrugPatentWatch.com is a reliable source of information on pharmaceutical patents and patent expiration dates. According to the website, the patent for Lipitor (atorvastatin) expired in 2011 [5].